Cell Culture Solutions
Pall's Allegro™ single use cell culture technologies are complete solutions that make your total upstream process robust and efficient, from R&D to full production scale. Whether you are growing adherent cells for cell therapy or vaccine applications, or have large volume suspension cell culture requirements, Pall now provides a large range of next generation single-use bioreactor systems offering performance improvements, operational simplicity, and improved reliability for your critical upstream operations. Supported by Pall's Process Development Services, Pall's solutions will take your process to the next level.
Innovative features emphasize ease of use for characterization, optimization and GMP manufacturing, providing a strong complement to the Pall range of bench scale single-use bioreactors.
The new Allegro™ STR 50 L bioreactor maintains direct scale-down engineering design concept from the Allegro STR 200 L bioreactor, supporting process development and cGMP manufacturing demands.
Pall SoloHill microcarriers are designed to support cell growth at a variety of scales: spinner flasks, microbioreactors, small to large scale stirred tank bioreactors, rocking platforms and microgravity bioreactors.
Ultroser™ G serum substitute can successfully replace FCS (fetal calf serum) in cell culture medium. It is designed for the in vitro culture of anchorage-dependent cells. It is specially tested as the primary culture from amniotic liquid cells and is designed to confirm their ability for karyotyping.
Partnering with our team of accelerator scientists provides extra support to meet accelerated timelines. Skilled cell culture scientists are available both remotely and on-site to assist with process development and optimization.
Allegro™ STR Single-Use Stirred Tank Bioreactors
The Allegro STR Single-Use Bioreactors are the industry’s most ergonomically-designed and operationally-intuitive bioreactor, available in 200 L, 1000 L, and 2000 L size. Safe operation, reduced footprint, and a direct bottom-driven impellor facilitating high kLa (up to 40 h-1) distinguish this next-generation system.
Cell Culture Products
Performance improvements, simple operations and improved reliability for your critical upstream operations
The cell culture industry has grown exponentially over the years to meet rising demands for drug development, vaccinations, and other biopharmaceutical contributions to the medical field. As research and production demands grow, updated equipment is needed to meet modern qualifications and regulations. The complexity of researching and handling delicate animal cells requires safe, sterile technology that is able to treat every detail of the cell culturing process with efficiency and precision.
The cell culture equipment manufactured by Pall Corporation addresses every need in the growing cell culture market. From vaccine development to large volume suspension cell culture requirements, Pall’s next generation cell culture technology will optimize and simplify performance. The equipment delivers reliable, efficient, cost-saving solutions for upstream and downstream operations. Single-use products offer sterility while multi-use mediums and filters provide versatile and economical ways to extend equipment life. All Pall products meet the strictest industry regulations and are guaranteed to enhance the quality of cell culture operations.
Pall Corporation provides equipment that meets the needs of the growing cell culture industry. Next generation, single-use bioreactors improve upstream processing and yield increased cell growth. 3D microcarriers maximize cell expansion and efficient harvesting. Pall Corporation also offers global support services by experts to guarantee proper maintenance and optimize the user experience of cell culture technology.
Pall’s cell culture technology applications offer economical and efficient solutions for the biopharmaceutical industry. Pall’s equipment ensures higher output rates at lower cost, making sure to keep to the highest standards of safety and cleanliness to prevent contamination. The technology is often versatile and adaptable to a range of applications within the laboratory, increasing and streamlining productivity.
Pall’s cell culture technology solutions enhance production quality in the biopharmaceutical industry. For more information on product features and utilizations, click through product pages.
ASK BIOPHARMACEUTICALS A QUESTION